Brief: Richter, Allergan get U.S. approval for expanded use of Vraylar
May 28 (Reuters) - Richter Gedeon Vegyeszeti Gyar Nyrt
GDRB.BU :
* RICHTER AND ALLERGAN RECEIVE U.S. FDA APPROVAL FOR
EXPANDED USE
OF VRAYLAR IN THE TREATMENT OF BIPOLAR DEPRESSION urn:newsml:reuters.com:*:nL4N2342RC
Further company coverage: GDRB.BU
(Reporting by Gergely Szakacs)
((gergely.szakacs@reuters.com ; https://twitter.com/szakacsg ;
+36 1 882 3606 ;
https://www.reuters.com/journalists/gergely-szakacs))
Recent news on Gedeon Richter
See all newsBrief: Hungary's Richter says US FDA accepted for review its new drug application for Fylrevy
Brief: Hungary's Richter Upgrades 2026 Pharma Clean EBIT Guidance To Double-Digit Growth
development partnership in Tirzepatide
AI in Hungary could unlock productivity gains of €15 billion, McKinsey says
Brief: Hungary's Richter and Hetero announce cooperation for development of semaglutide injection